Resultados de procura - Alice T. Shaw

Limitar resultados
  1. 1
    <i>ALK</i> in Lung Cancer: Past, Present, and Future

    <i>ALK</i> in Lung Cancer: Past, Present, and Future por Alice T. Shaw, Jeffrey A. Engelman

    Publicado 2013
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Novel Targets in Non-Small Cell Lung Cancer: <i>ROS1</i> and <i>RET</i> Fusions

    Novel Targets in Non-Small Cell Lung Cancer: <i>ROS1</i> and <i>RET</i> Fusions por Justin F. Gainor, Alice T. Shaw

    Publicado 2013
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Molecular Pathways: Resistance to Kinase Inhibitors and Implications for Therapeutic Strategies

    Molecular Pathways: Resistance to Kinase Inhibitors and Implications for Therapeutic Strategies por Christine M. Lovly, Alice T. Shaw

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Emerging Paradigms in the Development of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer

    Emerging Paradigms in the Development of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer por Justin F. Gainor, Alice T. Shaw

    Publicado 2013
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    Resisting Resistance: Targeted Therapies in Lung Cancer

    Resisting Resistance: Targeted Therapies in Lung Cancer por W. Marston Linehan, Alice T. Shaw

    Publicado 2016
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  6. 6
    Crizotinib resistance: implications for therapeutic strategies

    Crizotinib resistance: implications for therapeutic strategies por Ibiayi Dagogo‐Jack, Alice T. Shaw

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  7. 7
    Recent Advances in Targeting ROS1 in Lung Cancer

    Recent Advances in Targeting ROS1 in Lung Cancer por W. Marston Linehan, Alice T. Shaw

    Publicado 2017
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    Therapeutic Targeting of Anaplastic Lymphoma Kinase in Lung Cancer: A Paradigm for Precision Cancer Medicine

    Therapeutic Targeting of Anaplastic Lymphoma Kinase in Lung Cancer: A Paradigm for Precision Cancer Medicine por Ryohei Katayama, Christine M. Lovly, Alice T. Shaw

    Publicado 2015
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  9. 9
    Targeting ALK: Precision Medicine Takes on Drug Resistance

    Targeting ALK: Precision Medicine Takes on Drug Resistance por W. Marston Linehan, Gregory J. Riely, Alice T. Shaw

    Publicado 2017
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  10. 10
    Tyrosine kinase gene rearrangements in epithelial malignancies

    Tyrosine kinase gene rearrangements in epithelial malignancies por Alice T. Shaw, Peggy P. Hsu, Mark M. Awad, Jeffrey A. Engelman

    Publicado 2013
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  11. 11
    The Central Nervous System as a Sanctuary Site in ALK-Positive Non–Small-Cell Lung Cancer

    The Central Nervous System as a Sanctuary Site in ALK-Positive Non–Small-Cell Lung Cancer por Justin F. Gainor, Sai‐Hong Ignatius Ou, Jennifer Logan, Lawrence F. Borges, Alice T. Shaw

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer

    Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer por Meghan Campo, H. Al-Halabi, Melin J. Khandekar, Alice T. Shaw, Lecia V. Sequist, Henning Willers

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  13. 13
    Clinical Management of Adverse Events Associated with Lorlatinib

    Clinical Management of Adverse Events Associated with Lorlatinib por Todd M. Bauer, Enriqueta Felip, Benjamin Solomon, Holger Thurm, Gerson Peltz, Marc Chioda, Alice T. Shaw

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Cabozantinib Overcomes Crizotinib Resistance in ROS1 Fusion–Positive Cancer

    Cabozantinib Overcomes Crizotinib Resistance in ROS1 Fusion–Positive Cancer por Ryohei Katayama, Yuka Kobayashi, Luc Friboulet, Elizabeth L. Lockerman, Sumie Koike, Alice T. Shaw, Jeffrey A. Engelman, Naoya Fujita

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Osimertinib Responses After Disease Progression in Patients Who Had Been Receiving Rociletinib

    Osimertinib Responses After Disease Progression in Patients Who Had Been Receiving Rociletinib por Lecia V. Sequist, Zofia Piotrowska, Matthew J. Niederst, Rebecca S. Heist, Subba R. Digumarthy, Alice T. Shaw, Jeffrey A. Engelman

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Carta
    Engadir a favoritos
    Gardado en:
  16. 16
    Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer Relapsing on Standard Dose Alectinib

    Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer Relapsing on Standard Dose Alec... por Justin F. Gainor, S. Andrew, Jennifer Logan, Ranliang Hu, Kevin Oh, Priscilla K. Brastianos, Helen A. Shih, Alice T. Shaw

    Publicado 2015
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Nutrient intakes during pregnancy: observations on the influence of smoking and social class

    Nutrient intakes during pregnancy: observations on the influence of smoking and social class por F.M. Haste, OG Brooke, H R Anderson, J Martin Bland, Alice T. Shaw, Jane C. Griffin, Janet L. Peacock

    Publicado 1990
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Alectinib Salvages CNS Relapses in ALK-Positive Lung Cancer Patients Previously Treated with Crizotinib and Ceritinib

    Alectinib Salvages CNS Relapses in ALK-Positive Lung Cancer Patients Previously Treated with Crizotinib and Ceritinib por Justin F. Gainor, Carol A. Sherman, Kathryn Willoughby, Jennifer Logan, Elizabeth A. Kennedy, Priscilla K. Brastianos, S. Andrew, Alice T. Shaw

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Emergence of a RET V804M Gatekeeper Mutation During Treatment With Vandetanib in RET-Rearranged NSCLC

    Emergence of a RET V804M Gatekeeper Mutation During Treatment With Vandetanib in RET-Rearranged NSCLC por Ibiayi Dagogo‐Jack, Sara E. Stevens, W. Marston Linehan, Rebecca J. Nagy, Lorin A. Ferris, Alice T. Shaw, Justin F. Gainor

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Carta
    Engadir a favoritos
    Gardado en:
  20. 20
    ALK Mutation Status Before and After Alectinib Treatment in Locally Advanced or Metastatic ALK-Positive NSCLC: Pooled Analysis of Two Prospective Trials

    ALK Mutation Status Before and After Alectinib Treatment in Locally Advanced or Metastatic ALK-Positive NSCLC: Pooled Analysis of Two Prospective Trials por Johannes Noé, Alex Lovejoy, Sai‐Hong Ignatius Ou, Stephanie J. Yaung, Walter Bordogna, Daniel M. Klass, Craig Cummings, Alice T. Shaw

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: